ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Butylscopolamine Bromide Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-29C5764
Home | Market Reports | Health| Health Conditions| Pain Management
Global Butylscopolamine Bromide Market Insights and Forecast to 2028
BUY CHAPTERS

Global Butylscopolamine Bromide Market Research Report 2025

Code: QYRE-Auto-29C5764
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Boehringer Ingelheim
Sandoz(Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Wanbangde Pharmaceutical Group
Shandong Yijian Pharmaceutical
Boehringer Ingelheim Pharma GmbH & Co. KG

Butylscopolamine Bromide Market

The global market for Butylscopolamine Bromide was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Butylscopolamine is a peripherally acting antimuscarinic, anticholinergic agent. It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps, or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms. It is not a pain medication in the normal sense, since it does not directly affect pain, but rather works to prevent painful cramps and spasms from occurring. It is on the WHO Model List of Essential Medicines, the most important medications needed in a basic health system.
North American market for Butylscopolamine Bromide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Butylscopolamine Bromide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Butylscopolamine Bromide in Stomach is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Butylscopolamine Bromide include Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical, Jiangsu Ange Pharmaceutical, Chengdu First Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Butylscopolamine Bromide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Butylscopolamine Bromide.
The Butylscopolamine Bromide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Butylscopolamine Bromide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Butylscopolamine Bromide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Butylscopolamine Bromide Market Report

Report Metric Details
Report Name Butylscopolamine Bromide Market
Segment by Type
  • Tablets
  • Capsule
  • Intramuscular Injection
  • Intravenous Or Drip
  • Suppositories
  • Other
Segment by Application
  • Stomach
  • Gas Barium Hypography
  • Abdominal CT Scan
  • Gastrointestinal Spasm
  • Biliary Colic
  • Renal Colic
  • Gastrointestinal Hypermotility
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical, Jiangsu Ange Pharmaceutical, Chengdu First Pharmaceutical, Beijing Zizhu Pharmaceutical, Guangdong Zhongsheng Pharmaceutical, Wanbangde Pharmaceutical Group, Shandong Yijian Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Butylscopolamine Bromide company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Butylscopolamine Bromide Market report?

Ans: The main players in the Butylscopolamine Bromide Market are Sanofi, Boehringer Ingelheim, Sandoz (Novartis), Boehringer Ingelheim Pharma GmbH & Co. KG, XI AN TIANXINGJIAN PHARMCHEM, Linnea, Alkaloida, Chengdu Tiantaishan Pharmaceutical, Jiangsu Ange Pharmaceutical, Chengdu First Pharmaceutical, Beijing Zizhu Pharmaceutical, Guangdong Zhongsheng Pharmaceutical, Wanbangde Pharmaceutical Group, Shandong Yijian Pharmaceutical

What are the Application segmentation covered in the Butylscopolamine Bromide Market report?

Ans: The Applications covered in the Butylscopolamine Bromide Market report are Stomach, Gas Barium Hypography, Abdominal CT Scan, Gastrointestinal Spasm, Biliary Colic, Renal Colic, Gastrointestinal Hypermotility, Other

What are the Type segmentation covered in the Butylscopolamine Bromide Market report?

Ans: The Types covered in the Butylscopolamine Bromide Market report are Tablets, Capsule, Intramuscular Injection, Intravenous Or Drip, Suppositories, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Butylscopolamine Bromide Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Capsule
1.2.4 Intramuscular Injection
1.2.5 Intravenous Or Drip
1.2.6 Suppositories
1.2.7 Other
1.3 Market by Application
1.3.1 Global Butylscopolamine Bromide Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Stomach
1.3.3 Gas Barium Hypography
1.3.4 Abdominal CT Scan
1.3.5 Gastrointestinal Spasm
1.3.6 Biliary Colic
1.3.7 Renal Colic
1.3.8 Gastrointestinal Hypermotility
1.3.9 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Butylscopolamine Bromide Market Perspective (2020-2031)
2.2 Global Butylscopolamine Bromide Growth Trends by Region
2.2.1 Global Butylscopolamine Bromide Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Butylscopolamine Bromide Historic Market Size by Region (2020-2025)
2.2.3 Butylscopolamine Bromide Forecasted Market Size by Region (2026-2031)
2.3 Butylscopolamine Bromide Market Dynamics
2.3.1 Butylscopolamine Bromide Industry Trends
2.3.2 Butylscopolamine Bromide Market Drivers
2.3.3 Butylscopolamine Bromide Market Challenges
2.3.4 Butylscopolamine Bromide Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Butylscopolamine Bromide Players by Revenue
3.1.1 Global Top Butylscopolamine Bromide Players by Revenue (2020-2025)
3.1.2 Global Butylscopolamine Bromide Revenue Market Share by Players (2020-2025)
3.2 Global Butylscopolamine Bromide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Butylscopolamine Bromide Revenue
3.4 Global Butylscopolamine Bromide Market Concentration Ratio
3.4.1 Global Butylscopolamine Bromide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Butylscopolamine Bromide Revenue in 2024
3.5 Global Key Players of Butylscopolamine Bromide Head office and Area Served
3.6 Global Key Players of Butylscopolamine Bromide, Product and Application
3.7 Global Key Players of Butylscopolamine Bromide, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Butylscopolamine Bromide Breakdown Data by Type
4.1 Global Butylscopolamine Bromide Historic Market Size by Type (2020-2025)
4.2 Global Butylscopolamine Bromide Forecasted Market Size by Type (2026-2031)
5 Butylscopolamine Bromide Breakdown Data by Application
5.1 Global Butylscopolamine Bromide Historic Market Size by Application (2020-2025)
5.2 Global Butylscopolamine Bromide Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Butylscopolamine Bromide Market Size (2020-2031)
6.2 North America Butylscopolamine Bromide Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Butylscopolamine Bromide Market Size by Country (2020-2025)
6.4 North America Butylscopolamine Bromide Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Butylscopolamine Bromide Market Size (2020-2031)
7.2 Europe Butylscopolamine Bromide Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Butylscopolamine Bromide Market Size by Country (2020-2025)
7.4 Europe Butylscopolamine Bromide Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Butylscopolamine Bromide Market Size (2020-2031)
8.2 Asia-Pacific Butylscopolamine Bromide Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2020-2025)
8.4 Asia-Pacific Butylscopolamine Bromide Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Butylscopolamine Bromide Market Size (2020-2031)
9.2 Latin America Butylscopolamine Bromide Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Butylscopolamine Bromide Market Size by Country (2020-2025)
9.4 Latin America Butylscopolamine Bromide Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Butylscopolamine Bromide Market Size (2020-2031)
10.2 Middle East & Africa Butylscopolamine Bromide Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2020-2025)
10.4 Middle East & Africa Butylscopolamine Bromide Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Butylscopolamine Bromide Introduction
11.1.4 Sanofi Revenue in Butylscopolamine Bromide Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Butylscopolamine Bromide Introduction
11.2.4 Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2020-2025)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Sandoz (Novartis)
11.3.1 Sandoz (Novartis) Company Details
11.3.2 Sandoz (Novartis) Business Overview
11.3.3 Sandoz (Novartis) Butylscopolamine Bromide Introduction
11.3.4 Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2020-2025)
11.3.5 Sandoz (Novartis) Recent Development
11.4 Boehringer Ingelheim Pharma GmbH & Co. KG
11.4.1 Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
11.4.2 Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
11.4.3 Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Introduction
11.4.4 Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2020-2025)
11.4.5 Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
11.5 XI AN TIANXINGJIAN PHARMCHEM
11.5.1 XI AN TIANXINGJIAN PHARMCHEM Company Details
11.5.2 XI AN TIANXINGJIAN PHARMCHEM Business Overview
11.5.3 XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Introduction
11.5.4 XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2020-2025)
11.5.5 XI AN TIANXINGJIAN PHARMCHEM Recent Development
11.6 Linnea
11.6.1 Linnea Company Details
11.6.2 Linnea Business Overview
11.6.3 Linnea Butylscopolamine Bromide Introduction
11.6.4 Linnea Revenue in Butylscopolamine Bromide Business (2020-2025)
11.6.5 Linnea Recent Development
11.7 Alkaloida
11.7.1 Alkaloida Company Details
11.7.2 Alkaloida Business Overview
11.7.3 Alkaloida Butylscopolamine Bromide Introduction
11.7.4 Alkaloida Revenue in Butylscopolamine Bromide Business (2020-2025)
11.7.5 Alkaloida Recent Development
11.8 Chengdu Tiantaishan Pharmaceutical
11.8.1 Chengdu Tiantaishan Pharmaceutical Company Details
11.8.2 Chengdu Tiantaishan Pharmaceutical Business Overview
11.8.3 Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Introduction
11.8.4 Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.8.5 Chengdu Tiantaishan Pharmaceutical Recent Development
11.9 Jiangsu Ange Pharmaceutical
11.9.1 Jiangsu Ange Pharmaceutical Company Details
11.9.2 Jiangsu Ange Pharmaceutical Business Overview
11.9.3 Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Introduction
11.9.4 Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.9.5 Jiangsu Ange Pharmaceutical Recent Development
11.10 Chengdu First Pharmaceutical
11.10.1 Chengdu First Pharmaceutical Company Details
11.10.2 Chengdu First Pharmaceutical Business Overview
11.10.3 Chengdu First Pharmaceutical Butylscopolamine Bromide Introduction
11.10.4 Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.10.5 Chengdu First Pharmaceutical Recent Development
11.11 Beijing Zizhu Pharmaceutical
11.11.1 Beijing Zizhu Pharmaceutical Company Details
11.11.2 Beijing Zizhu Pharmaceutical Business Overview
11.11.3 Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Introduction
11.11.4 Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.11.5 Beijing Zizhu Pharmaceutical Recent Development
11.12 Guangdong Zhongsheng Pharmaceutical
11.12.1 Guangdong Zhongsheng Pharmaceutical Company Details
11.12.2 Guangdong Zhongsheng Pharmaceutical Business Overview
11.12.3 Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Introduction
11.12.4 Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.12.5 Guangdong Zhongsheng Pharmaceutical Recent Development
11.13 Wanbangde Pharmaceutical Group
11.13.1 Wanbangde Pharmaceutical Group Company Details
11.13.2 Wanbangde Pharmaceutical Group Business Overview
11.13.3 Wanbangde Pharmaceutical Group Butylscopolamine Bromide Introduction
11.13.4 Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2020-2025)
11.13.5 Wanbangde Pharmaceutical Group Recent Development
11.14 Shandong Yijian Pharmaceutical
11.14.1 Shandong Yijian Pharmaceutical Company Details
11.14.2 Shandong Yijian Pharmaceutical Business Overview
11.14.3 Shandong Yijian Pharmaceutical Butylscopolamine Bromide Introduction
11.14.4 Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025)
11.14.5 Shandong Yijian Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
Boehringer Ingelheim
Sandoz(Novartis)
Boehringer Ingelheim Pharma GmbH & Co. KG
XI AN TIANXINGJIAN PHARMCHEM
Linnea
Alkaloida
Chengdu Tiantaishan pharmaceutical
Jiangsu Ange Pharmaceutical
Chengdu First Pharmaceutical
Beijing Zizhu Pharmaceutical
Guangdong Zhongsheng Pharmaceutical
Wanbangde Pharmaceutical Group
Shandong Yijian Pharmaceutical
Boehringer Ingelheim Pharma GmbH & Co. KG
List of Tables
 Table 1. Global Butylscopolamine Bromide Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Capsule
 Table 4. Key Players of Intramuscular Injection
 Table 5. Key Players of Intravenous Or Drip
 Table 6. Key Players of Suppositories
 Table 7. Key Players of Other
 Table 8. Global Butylscopolamine Bromide Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Butylscopolamine Bromide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Butylscopolamine Bromide Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Butylscopolamine Bromide Market Share by Region (2020-2025)
 Table 12. Global Butylscopolamine Bromide Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Butylscopolamine Bromide Market Share by Region (2026-2031)
 Table 14. Butylscopolamine Bromide Market Trends
 Table 15. Butylscopolamine Bromide Market Drivers
 Table 16. Butylscopolamine Bromide Market Challenges
 Table 17. Butylscopolamine Bromide Market Restraints
 Table 18. Global Butylscopolamine Bromide Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Butylscopolamine Bromide Market Share by Players (2020-2025)
 Table 20. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2024)
 Table 21. Ranking of Global Top Butylscopolamine Bromide Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Butylscopolamine Bromide Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Butylscopolamine Bromide, Headquarters and Area Served
 Table 24. Global Key Players of Butylscopolamine Bromide, Product and Application
 Table 25. Global Key Players of Butylscopolamine Bromide, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Butylscopolamine Bromide Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Butylscopolamine Bromide Revenue Market Share by Type (2020-2025)
 Table 29. Global Butylscopolamine Bromide Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Butylscopolamine Bromide Revenue Market Share by Type (2026-2031)
 Table 31. Global Butylscopolamine Bromide Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Butylscopolamine Bromide Revenue Market Share by Application (2020-2025)
 Table 33. Global Butylscopolamine Bromide Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Butylscopolamine Bromide Revenue Market Share by Application (2026-2031)
 Table 35. North America Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Butylscopolamine Bromide Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Butylscopolamine Bromide Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Butylscopolamine Bromide Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Butylscopolamine Bromide Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Butylscopolamine Bromide Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Butylscopolamine Bromide Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Butylscopolamine Bromide Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Butylscopolamine Bromide Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Butylscopolamine Bromide Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Butylscopolamine Bromide Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Sanofi Company Details
 Table 51. Sanofi Business Overview
 Table 52. Sanofi Butylscopolamine Bromide Product
 Table 53. Sanofi Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 54. Sanofi Recent Development
 Table 55. Boehringer Ingelheim Company Details
 Table 56. Boehringer Ingelheim Business Overview
 Table 57. Boehringer Ingelheim Butylscopolamine Bromide Product
 Table 58. Boehringer Ingelheim Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 59. Boehringer Ingelheim Recent Development
 Table 60. Sandoz (Novartis) Company Details
 Table 61. Sandoz (Novartis) Business Overview
 Table 62. Sandoz (Novartis) Butylscopolamine Bromide Product
 Table 63. Sandoz (Novartis) Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 64. Sandoz (Novartis) Recent Development
 Table 65. Boehringer Ingelheim Pharma GmbH & Co. KG Company Details
 Table 66. Boehringer Ingelheim Pharma GmbH & Co. KG Business Overview
 Table 67. Boehringer Ingelheim Pharma GmbH & Co. KG Butylscopolamine Bromide Product
 Table 68. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 69. Boehringer Ingelheim Pharma GmbH & Co. KG Recent Development
 Table 70. XI AN TIANXINGJIAN PHARMCHEM Company Details
 Table 71. XI AN TIANXINGJIAN PHARMCHEM Business Overview
 Table 72. XI AN TIANXINGJIAN PHARMCHEM Butylscopolamine Bromide Product
 Table 73. XI AN TIANXINGJIAN PHARMCHEM Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 74. XI AN TIANXINGJIAN PHARMCHEM Recent Development
 Table 75. Linnea Company Details
 Table 76. Linnea Business Overview
 Table 77. Linnea Butylscopolamine Bromide Product
 Table 78. Linnea Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 79. Linnea Recent Development
 Table 80. Alkaloida Company Details
 Table 81. Alkaloida Business Overview
 Table 82. Alkaloida Butylscopolamine Bromide Product
 Table 83. Alkaloida Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 84. Alkaloida Recent Development
 Table 85. Chengdu Tiantaishan Pharmaceutical Company Details
 Table 86. Chengdu Tiantaishan Pharmaceutical Business Overview
 Table 87. Chengdu Tiantaishan Pharmaceutical Butylscopolamine Bromide Product
 Table 88. Chengdu Tiantaishan Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 89. Chengdu Tiantaishan Pharmaceutical Recent Development
 Table 90. Jiangsu Ange Pharmaceutical Company Details
 Table 91. Jiangsu Ange Pharmaceutical Business Overview
 Table 92. Jiangsu Ange Pharmaceutical Butylscopolamine Bromide Product
 Table 93. Jiangsu Ange Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 94. Jiangsu Ange Pharmaceutical Recent Development
 Table 95. Chengdu First Pharmaceutical Company Details
 Table 96. Chengdu First Pharmaceutical Business Overview
 Table 97. Chengdu First Pharmaceutical Butylscopolamine Bromide Product
 Table 98. Chengdu First Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 99. Chengdu First Pharmaceutical Recent Development
 Table 100. Beijing Zizhu Pharmaceutical Company Details
 Table 101. Beijing Zizhu Pharmaceutical Business Overview
 Table 102. Beijing Zizhu Pharmaceutical Butylscopolamine Bromide Product
 Table 103. Beijing Zizhu Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 104. Beijing Zizhu Pharmaceutical Recent Development
 Table 105. Guangdong Zhongsheng Pharmaceutical Company Details
 Table 106. Guangdong Zhongsheng Pharmaceutical Business Overview
 Table 107. Guangdong Zhongsheng Pharmaceutical Butylscopolamine Bromide Product
 Table 108. Guangdong Zhongsheng Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 109. Guangdong Zhongsheng Pharmaceutical Recent Development
 Table 110. Wanbangde Pharmaceutical Group Company Details
 Table 111. Wanbangde Pharmaceutical Group Business Overview
 Table 112. Wanbangde Pharmaceutical Group Butylscopolamine Bromide Product
 Table 113. Wanbangde Pharmaceutical Group Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 114. Wanbangde Pharmaceutical Group Recent Development
 Table 115. Shandong Yijian Pharmaceutical Company Details
 Table 116. Shandong Yijian Pharmaceutical Business Overview
 Table 117. Shandong Yijian Pharmaceutical Butylscopolamine Bromide Product
 Table 118. Shandong Yijian Pharmaceutical Revenue in Butylscopolamine Bromide Business (2020-2025) & (US$ Million)
 Table 119. Shandong Yijian Pharmaceutical Recent Development
 Table 120. Research Programs/Design for This Report
 Table 121. Key Data Information from Secondary Sources
 Table 122. Key Data Information from Primary Sources
 Table 123. Authors List of This Report


List of Figures
 Figure 1. Butylscopolamine Bromide Picture
 Figure 2. Global Butylscopolamine Bromide Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Butylscopolamine Bromide Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Capsule Features
 Figure 6. Intramuscular Injection Features
 Figure 7. Intravenous Or Drip Features
 Figure 8. Suppositories Features
 Figure 9. Other Features
 Figure 10. Global Butylscopolamine Bromide Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Butylscopolamine Bromide Market Share by Application: 2024 VS 2031
 Figure 12. Stomach Case Studies
 Figure 13. Gas Barium Hypography Case Studies
 Figure 14. Abdominal CT Scan Case Studies
 Figure 15. Gastrointestinal Spasm Case Studies
 Figure 16. Biliary Colic Case Studies
 Figure 17. Renal Colic Case Studies
 Figure 18. Gastrointestinal Hypermotility Case Studies
 Figure 19. Other Case Studies
 Figure 20. Butylscopolamine Bromide Report Years Considered
 Figure 21. Global Butylscopolamine Bromide Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 22. Global Butylscopolamine Bromide Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 23. Global Butylscopolamine Bromide Market Share by Region: 2024 VS 2031
 Figure 24. Global Butylscopolamine Bromide Market Share by Players in 2024
 Figure 25. Global Top Butylscopolamine Bromide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Butylscopolamine Bromide as of 2024)
 Figure 26. The Top 10 and 5 Players Market Share by Butylscopolamine Bromide Revenue in 2024
 Figure 27. North America Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. North America Butylscopolamine Bromide Market Share by Country (2020-2031)
 Figure 29. United States Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Canada Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Europe Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Europe Butylscopolamine Bromide Market Share by Country (2020-2031)
 Figure 33. Germany Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. France Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. U.K. Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Italy Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Russia Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Nordic Countries Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Asia-Pacific Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Asia-Pacific Butylscopolamine Bromide Market Share by Region (2020-2031)
 Figure 41. China Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Japan Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. South Korea Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Southeast Asia Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. India Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Australia Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Latin America Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Latin America Butylscopolamine Bromide Market Share by Country (2020-2031)
 Figure 49. Mexico Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Brazil Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Middle East & Africa Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Middle East & Africa Butylscopolamine Bromide Market Share by Country (2020-2031)
 Figure 53. Turkey Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 55. UAE Butylscopolamine Bromide Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 56. Sanofi Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 57. Boehringer Ingelheim Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 58. Sandoz (Novartis) Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 59. Boehringer Ingelheim Pharma GmbH & Co. KG Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 60. XI AN TIANXINGJIAN PHARMCHEM Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 61. Linnea Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 62. Alkaloida Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 63. Chengdu Tiantaishan Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 64. Jiangsu Ange Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 65. Chengdu First Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 66. Beijing Zizhu Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 67. Guangdong Zhongsheng Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 68. Wanbangde Pharmaceutical Group Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 69. Shandong Yijian Pharmaceutical Revenue Growth Rate in Butylscopolamine Bromide Business (2020-2025)
 Figure 70. Bottom-up and Top-down Approaches for This Report
 Figure 71. Data Triangulation
 Figure 72. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Hyoscine N Butyl Bromide Market Insights Forecast to 2030
Global Scopolamine Butylbromide Injection Market Research Report 2025
Global Scopolamine Butylbromide Capsules Market Research Report 2024
Global Scopolamine Butylbromide for Injection Market Research Report 2024
Global Scopolamine Butyl Bromide API Market Research Report 2025
Propantheline Bromide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Clidinium Bromide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Research Report 2024
N Butylbenzenesulfonamide BBSA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Hyoscine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Methylene Bis Butylthioglycolate Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Scopolamine Market Insights Forecast to 2030
Global Bromoacetyl Bromide Market Research Report 2025
Global Butyl Rubber Piston for Pre Filling Syringe Market Research Report 2025
Global High Purity N Butylbenzenesulfonamide Market Research Report 2024
Global Otilonium Bromide API Market Research Report 2024
Global Warming Agent Vanillyl Butyl Ether Market Research Report 2025
Butyl Cellosolve Acetate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti spasmodic Drugs Market Insights Forecast to 2030
Global Mebeverine Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions